SELLAS Life Sciences Group Inc (SLS)
1.17
-0.05
(-4.10%)
USD |
NASDAQ |
Nov 22, 16:00
1.165
0.00 (0.00%)
After-Hours: 20:00
SELLAS Life Sciences Group Cash from Operations (Quarterly): -7.806M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -7.806M |
| June 30, 2024 | -9.682M |
| March 31, 2024 | -10.76M |
| December 31, 2023 | -4.825M |
| September 30, 2023 | -6.892M |
| June 30, 2023 | -7.566M |
| March 31, 2023 | -12.13M |
| December 31, 2022 | -5.152M |
| September 30, 2022 | -5.746M |
| June 30, 2022 | -5.761M |
| March 31, 2022 | -7.15M |
| December 31, 2021 | -4.976M |
| September 30, 2021 | -5.878M |
| June 30, 2021 | -4.898M |
| March 31, 2021 | -10.27M |
| December 31, 2020 | 3.424M |
| September 30, 2020 | -3.629M |
| June 30, 2020 | -3.381M |
| March 31, 2020 | -6.831M |
| December 31, 2019 | -4.176M |
| September 30, 2019 | -3.82M |
| June 30, 2019 | -4.656M |
| March 31, 2019 | -4.991M |
| December 31, 2018 | -4.555M |
| September 30, 2018 | -14.16M |
| Date | Value |
|---|---|
| June 30, 2018 | -6.299M |
| March 31, 2018 | -5.403M |
| December 31, 2017 | 15.25M |
| September 30, 2017 | -19.39M |
| June 30, 2017 | -3.049M |
| March 31, 2017 | -3.803M |
| December 31, 2016 | 25.06M |
| September 30, 2016 | -12.21M |
| June 30, 2016 | -11.49M |
| March 31, 2016 | -13.22M |
| December 31, 2015 | -15.28M |
| September 30, 2015 | -9.46M |
| June 30, 2015 | -11.86M |
| March 31, 2015 | -11.56M |
| December 31, 2014 | -10.73M |
| September 30, 2014 | -11.12M |
| June 30, 2014 | -12.97M |
| March 31, 2014 | -8.048M |
| December 31, 2013 | -8.492M |
| September 30, 2013 | -7.983M |
| June 30, 2013 | -7.123M |
| March 31, 2013 | -5.331M |
| December 31, 2012 | -5.178M |
| September 30, 2012 | -4.165M |
| June 30, 2012 | -6.745M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-12.13M
Minimum
Mar 2023
3.424M
Maximum
Dec 2020
-6.204M
Average
-5.820M
Median
Cash from Operations (Quarterly) Benchmarks
| Microbot Medical Inc | -2.759M |
| Alaunos Therapeutics Inc | -0.781M |
| Galectin Therapeutics Inc | -8.538M |
| Oragenics Inc | -1.970M |
| Anavex Life Sciences Corp | -5.18M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 19.69M |
| Free Cash Flow | -33.07M |
| Free Cash Flow Per Share (Quarterly) | -0.1144 |
| Free Cash Flow Yield | -56.12% |